AU2002323894A1 - Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use - Google Patents

Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use

Info

Publication number
AU2002323894A1
AU2002323894A1 AU2002323894A AU2002323894A AU2002323894A1 AU 2002323894 A1 AU2002323894 A1 AU 2002323894A1 AU 2002323894 A AU2002323894 A AU 2002323894A AU 2002323894 A AU2002323894 A AU 2002323894A AU 2002323894 A1 AU2002323894 A1 AU 2002323894A1
Authority
AU
Australia
Prior art keywords
costimulating
preparation
monoclonal antibodies
cell polypeptide
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002323894A
Other versions
AU2002323894B2 (en
Inventor
Richard Kroczek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Robert Koch Institute
Original Assignee
Robert Koch Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU13320/99A external-priority patent/AU752433B2/en
Application filed by Robert Koch Institute filed Critical Robert Koch Institute
Priority to AU2002323894A priority Critical patent/AU2002323894B2/en
Priority claimed from AU2002323894A external-priority patent/AU2002323894B2/en
Publication of AU2002323894A1 publication Critical patent/AU2002323894A1/en
Application granted granted Critical
Publication of AU2002323894B2 publication Critical patent/AU2002323894B2/en
Assigned to Bundesrepublik Deutschland letzvertreten durch Den Direktor des Robert-Koch-Instituts reassignment Bundesrepublik Deutschland letzvertreten durch Den Direktor des Robert-Koch-Instituts Request for Assignment Assignors: BUNDESREPUBLIK DEUTSCHLAND LETZVERTRETEN DURCH DEN DIREKTOR DES ROBER-KOCH-INSTITUTS
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002323894A 1997-09-23 2002-12-19 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use Ceased AU2002323894B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002323894A AU2002323894B2 (en) 1997-09-23 2002-12-19 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19741929 1997-09-23
DE19821060 1998-05-11
AU13320/99A AU752433B2 (en) 1997-09-23 1998-09-23 Costimulating T-cell polypeptide, monoclonal antibodies, their preparation and use
PCT/DE1998/002896 WO1999015553A2 (en) 1997-09-23 1998-09-23 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use
AU2002323894A AU2002323894B2 (en) 1997-09-23 2002-12-19 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU13320/99A Division AU752433B2 (en) 1997-09-23 1998-09-23 Costimulating T-cell polypeptide, monoclonal antibodies, their preparation and use

Publications (2)

Publication Number Publication Date
AU2002323894A1 true AU2002323894A1 (en) 2003-05-15
AU2002323894B2 AU2002323894B2 (en) 2006-10-12

Family

ID=39357301

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002323894A Ceased AU2002323894B2 (en) 1997-09-23 2002-12-19 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use

Country Status (1)

Country Link
AU (1) AU2002323894B2 (en)

Similar Documents

Publication Publication Date Title
AU1332099A (en) Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use
AU1462300A (en) Human pan-hcv human monoclonal antibodies
AU735411C (en) Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies
AU2958997A (en) Concentrated antibody preparation
AU2508499A (en) Ligands of the cd47 antigen, agents binding the ligands of the cd47 antigen and uses thereof
AU4042195A (en) Anti-alphaV-integrin monoclonal antibody
AU4397297A (en) Antibody against human parathormone related peptides
AU4426296A (en) G protein coupled receptor protein, production, and use thereof
AU7237496A (en) Methods and compositions comprising single chain recombinant antibodies
AU7676300A (en) Human anti-adipocyte monoclonal antibodies and their use
AU3576797A (en) Anti-cocaine catalytic antibody
AU6702998A (en) Anti-alphabeta3 humanized monoclonal antibodies
AU2597897A (en) Peptide ligands of the urokinase receptor
AU4606196A (en) Assay, receptor proteins and ligands
AU7541296A (en) Beta-fructofuranosidase, its preparation and uses
AU7072998A (en) Immunoassays using anti-allotypic monoclonal antibodies
AU6692598A (en) Growth factor receptor binding protein
AU5021796A (en) Recombinant human anti-lewis b antibodies
AU1538497A (en) Anti-gp46 antibodies and fragments thereof and their use
AU4373197A (en) Recombinant single chain antibodies directed against the gp54 cancer marker, composition comprising same and use thereof
AU1110297A (en) Novel dnas, novel polypeptides and novel antibodies
AU4256096A (en) Monoclonal antibody fragments having immunosuppressant activity
EP0977590A4 (en) Human monoclonal antibodies
AU3458299A (en) Monoclonal antibodies against (campylobacter jejuni) and (campylobacter coli) outer membrane antigens
AU1373395A (en) Vpr receptor protein